Search research articles
Contact Us
Filters
Showing results (131-140 of 176) with videos related to
Page
of 18
Sort By:
Blood
|
October 25, 2023
Three-year follow-up analysis of axicabtagene ciloleucel in relapsed/refractory indolent non-Hodgkin lymphoma (ZUMA-5)
Sattva S Neelapu, Julio C Chavez, Alison R Sehgal, et al.
Nature Medicine
|
October 9, 2023
Publisher Correction: Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial
Roch Houot, Emmanuel Bachy, Guillaume Cartron, et al.
American Journal of Hematology
|
July 29, 2016
Early event status informs subsequent outcome in newly diagnosed follicular lymphoma
Matthew J Maurer, Emmanuel Bachy, Hervé Ghesquières, et al.
Blood
|
April 19, 2018
A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy
Emmanuel Bachy, Matthew J Maurer, Thomas M Habermann, et al.
The Lancet. Oncology
|
November 1, 2024
Valemetostat for patients with relapsed or refractory peripheral T-cell lymphoma (VALENTINE-PTCL01): a multicentre, open-label, single-arm, phase 2 study
Pier Luigi Zinzani, Koji Izutsu, Neha Mehta-Shah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 18, 2023
Randomized Phase III Trial Evaluating Subcutaneous Rituximab for the First-Line Treatment of Low-Tumor Burden Follicular Lymphoma: Results of a LYSA Study
Guillaume Cartron, Emmanuel Bachy, Hervé Tilly, et al.
Haematologica
|
June 20, 2024
Brexucabtagene autoleucel in relapsed or refractory mantle cell lymphoma, intention-to-treat use in the DESCAR-T registry
Charles Herbaux, Caroline Bret, Emmanuel Bachy, et al.
Cancer Cell
|
July 31, 2018
Targeting the HTLV-I-Regulated BATF3/IRF4 Transcriptional Network in Adult T Cell Leukemia/Lymphoma
Masao Nakagawa, Arthur L Shaffer, Michele Ceribelli, et al.
Haematologica
|
March 9, 2023
Post-transplantation Burkitt lymphoma: a retrospective study of 55 patients
Pierre Walczak, Sylvain Choquet, Jacques Dantal, et al.
The Lancet. Haematology
|
May 25, 2024
Oral azacitidine compared with standard therapy in patients with relapsed or refractory follicular helper T-cell lymphoma (ORACLE): an open-label randomised, phase 3 study
Jehan Dupuis, Emmanuel Bachy, Franck Morschhauser, et al.
Page
of 18
Search research articles
Search
Showing results (131-140 of 176) with videos related to
Sort By:
Page
of 18
Blood
|
October 25, 2023
Three-year follow-up analysis of axicabtagene ciloleucel in relapsed/refractory indolent non-Hodgkin lymphoma (ZUMA-5)
Sattva S Neelapu, Julio C Chavez, Alison R Sehgal, et al.
Nature Medicine
|
October 9, 2023
Publisher Correction: Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial
Roch Houot, Emmanuel Bachy, Guillaume Cartron, et al.
American Journal of Hematology
|
July 29, 2016
Early event status informs subsequent outcome in newly diagnosed follicular lymphoma
Matthew J Maurer, Emmanuel Bachy, Hervé Ghesquières, et al.
Blood
|
April 19, 2018
A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy
Emmanuel Bachy, Matthew J Maurer, Thomas M Habermann, et al.
The Lancet. Oncology
|
November 1, 2024
Valemetostat for patients with relapsed or refractory peripheral T-cell lymphoma (VALENTINE-PTCL01): a multicentre, open-label, single-arm, phase 2 study
Pier Luigi Zinzani, Koji Izutsu, Neha Mehta-Shah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 18, 2023
Randomized Phase III Trial Evaluating Subcutaneous Rituximab for the First-Line Treatment of Low-Tumor Burden Follicular Lymphoma: Results of a LYSA Study
Guillaume Cartron, Emmanuel Bachy, Hervé Tilly, et al.
Haematologica
|
June 20, 2024
Brexucabtagene autoleucel in relapsed or refractory mantle cell lymphoma, intention-to-treat use in the DESCAR-T registry
Charles Herbaux, Caroline Bret, Emmanuel Bachy, et al.
Cancer Cell
|
July 31, 2018
Targeting the HTLV-I-Regulated BATF3/IRF4 Transcriptional Network in Adult T Cell Leukemia/Lymphoma
Masao Nakagawa, Arthur L Shaffer, Michele Ceribelli, et al.
Haematologica
|
March 9, 2023
Post-transplantation Burkitt lymphoma: a retrospective study of 55 patients
Pierre Walczak, Sylvain Choquet, Jacques Dantal, et al.
The Lancet. Haematology
|
May 25, 2024
Oral azacitidine compared with standard therapy in patients with relapsed or refractory follicular helper T-cell lymphoma (ORACLE): an open-label randomised, phase 3 study
Jehan Dupuis, Emmanuel Bachy, Franck Morschhauser, et al.
Page
of 18